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APOBEC3G (Apo3G) is a single-stranded DNA-dependent
deoxycytidine deaminase, which, in the absence of the human
immunodeficiency virus (HIV) viral infectivity factor, is encap-
sulated into HIV virions. Subsequently, Apo3G triggers viral
inactivation by processively deaminating C3U, with 335
polarity, on nascent minus-strand cDNA. Apo3G has a catalyti-
cally inactive N-terminal CD1 domain and an active C-terminal
CD2 domain. Apo3G exists as monomers, dimers, tetramers,
and higher order oligomers whose distributions depend on
DNA substrate and salt. Here we use multiangle light scattering
and atomic force microscopy to identify oligomerization states
of Apo3G. A double mutant (F126A/W127A), designed to dis-
rupt dimerization at the predicted CD1-CD1 dimer interface,
predominantly convertsApo3G to amonomer that binds single-
strandedDNA,AluRNA, and catalyzes processiveC3Udeami-
nations with 335 deamination polarity, similar to native
Apo3G. The CD1 domain is essential for both processivity and
polarity. We propose a structure-based model to explain the
scanning and catalytic behavior of Apo3G.
Human APOBEC3G (Apo3G)3 is a single-stranded DNA
(ssDNA) deoxycytidine deaminase that can restrict replication
of HIV in strains lacking the virus infectivity factor protein (1).
Virus infectivity factor facilitates polyubiquitination of Apo3G,
resulting in proteasomal degradation (2–6). When virus infec-
tivity factor is absent, however, Apo3G is encapsulated in the
HIV virus particle, most likely as a multimer (7), through inter-
actions with HIV RNA or 7SL RNA and the nucleocapsid por-
tion ofGag (7–15). Following release from theHIVvirion intoT
cells, Apo3G generates large numbers of deaminations, typi-
cally 5-CCC3CCU, in viral () single-stranded cDNAduring
reverse transcription (16–18). Subsequent replication of the
cDNA generates G3A mutations in HIV () DNA, causing
proviral inactivation (16–18). As a counterpart to its role as a
C-deaminase, Apo3G also has a non-enzymatic cellular func-
tion. It restricts retrotransposition by binding Alu RNA tran-
scripts in the cytoplasm, thereby blocking the transposition
cycle (19).
In this study, we address the relationship of Apo3G structure
to biochemical function. An Apo3Gmonomer has two homol-
ogous deaminase domains, an active C-terminal domain (CD2)
required for catalysis and motif specificity and a catalytically
inactive N-terminal domain (CD1) needed for DNA and RNA
binding (20, 21). The CD1 domain is believed to be required for
the incorporation of Apo3G into virions (21).
Apo3G deaminates ssDNA processively, with a strongly
polar 335 deamination bias (22, 23). There is no obvious
energy source, e.g. ATP or GTP (22). Therefore, the processive
sliding and jumping/hopping motions must be random, yet the
deaminations are decidedly non-random (22, 23). Therefore,
the spatial deamination bias must be a catalytic bias, not a
motional bias. The question is: “What is the biochemical/struc-
tural mechanism?”
There was an overriding serious impediment in the way of
addressing the mechanism because highly purified native
Apo3G is composed of monomers, dimers, trimers, tetramers,
and higher order oligomers in the absence of DNA (23, 24),
whose relative amounts change dramatically when bound to
ssDNAand show additional changes in composition depending
on salt concentration (23). Apo3G may be present as an olig-
omer bound to RNA when released from the HIV virion into a
T cell (7, 25), but most, if not all, of the RNAmust be degraded
to activateApo3G for catalysis (25, 26). Thereafter, the function
of the oligomer is uncertain. Does Apo3G work solely as a
dimer, as is currently thought (24, 27), or alternatively, as a
combination of monomers and oligomers (23)?
Here we investigate the biochemical properties of an Sf9-
expressed Apo3G mutant, F126A/W127A. This mutant was
designed to disrupt dimerization based on structures of
APOBEC2 (Apo2) (28) and the Apo3G-CD2 catalytic domain
(29). We analyze the ssDNA scanning and C-deamination
properties of the monomer and the Apo3G-CD2 catalytic
domain (in the absence ofCD1) relative to those of the naturally
occurring heterogeneous assortment of Apo3Gmonomers and
oligomers (23, 24).We propose a model to account for the pro-
cessive and polar characteristics of Apo3G-catalyzed deamina-
tion on ssDNAbased on biochemical comparisons of the native
* This work was supported, in whole or in part, by National Institutes of Health
Grants ESO13192 and R37GM21422 (to M. F. G.), GM080294 and
GM079480 (to D. A. E.), and GM087986 (to X. S. C.). This work was also sup-
ported by a California HIV/AIDS Research Program grant (to X. S. C.).
 This article was selected as a Paper of the Week.
□S The on-line version of this article (available at http://www.jbc.org) contains
supplemental Experimental Procedures, Tables S1–S3, and Figs. S1–S7.
1 Present address: Dept. of Microbiology and Immunology, University of Sas-
katchewan, Saskatoon, Saskatchewan S7N 5E5, Canada.
2 To whom correspondence should be addressed: 1050 Childs Way, Los Ange-
les, CA 90089. Fax: 213-821-1138; E-mail: mgoodman@usc.edu.
3 The abbreviations used are: Apo3G, APOBEC3G; ssDNA, single-stranded
DNA; HIV, human immunodeficiency virus; CD2, C-terminal domain; CD1,
N-terminal domain; MALS, multiangle light scattering; AFM, atomic force
microscopy; nt, nucleotides; F/W, F126A/W127A.
THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 285, NO. 21, pp. 16195–16205, May 21, 2010
© 2010 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in the U.S.A.
MAY 21, 2010 • VOLUME 285 • NUMBER 21 JOURNAL OF BIOLOGICAL CHEMISTRY 16195
and Apo3G monomer, in conjunction with structural studies
on Apo2 (28) and Apo3G-CD2 (29).
EXPERIMENTAL PROCEDURES
Apo2 and Apo3G Structural Modeling—The predicted
model of Apo3G CD1 was obtained by using the interactive
SWISS-MODELprogramusing the homologousApo2 (Protein
Data Bank (PDB): 2nyt) structure as a template (see Fig. 1B). For
the Apo3G dimer head-head configuration (see Fig. 1D), the
Apo3G-CD1 model was aligned with each Apo2 monomer in
the Apo2 tetrameric interface. For the Apo3G dimer tail-tail
configuration (see Fig. 1E), the Apo3G-CD2 (PDB: 3e1u) struc-
tures were aligned with each Apo2 monomer in the tetrameric
interface. All figures were made using PyMOL.
Substrates—DNA oligonucleotides were synthesized on an
Applied Biosystems 3400 DNA/RNA synthesizer and are listed
in supplemental Table S1. Fluorescein-dT was purchased from
Glen Research. Fluorescently labeled RNA was produced by
transcribing the DNA sequence, cloned into the pSP72 vector
(Promega) using XhoI and HindIII sites, with SP6 RNA poly-
merase with a pool of nucleotides containing fluorescein-12-
UTP (Roche Applied Science).
Apo3G Expression and Purification—A baculovirus-ex-
pressedGST-Apo3G protein was constructed as described pre-
viously (22). Apo3G-CD2 domain (amino acids 197–380) was
cloned into XmaI and EcoRI sites in the pAcG2T vector (BD
Biosciences). Apo3G recombinant virus was obtained as
described previously (30). Sf9 cells were infected with recombi-
nant Apo3G virus at a multiplicity of infection of 1 and har-
vested after 72 h. Cells were lysed as described previously (22) in
the presence of 50 g ml1 of RNase A. Cleared lysates were
then incubated with glutathione-Sepharose resin (GE Health-
care) and subjected to a series of salt washes (0.25–1 M NaCl)
(23) before on-column cleavage of the glutathione S-transferase
tag with 40 units of thrombin (Calbiochem) for 16 h at 21 °C.
Cleaved Apo3G fractions were collected and stored at 70 °C.
Apo3G is 95% pure.
Site-directed Mutagenesis—Mutant Apo3G proteins were
constructed by site-directedmutagenesis (QuikChange site-di-
rectedmutagenesis protocol, Stratagene) withmodifications by
Wang and Malcom (31) using the pAcG2T-Apo3G vector as
the template (22). The primers that were used are listed in
supplemental Table S2.
Multiangle Light Scattering (MALS)—Apo3G (50–100 g in
30 l) was subjected to size-exclusion chromatography using a
silica-based column (8-nm diameter, 300-mm length, KW-803
Shodex). A solution containing 50 mMHEPES, pH 6.7, and 200
mMNaSO4 was used as the eluent buffer. Chromatography was
performed at 0.5mlmin1, and the column effluent was passed
directly on-line intoaMALSdetector (DawnHeleos,WyattTech-
nology) and refractometer (Optilab rEX,WyattTechnology).Data
analysis to determine molecular masses was performed with
ASTRA software. Experiments were conducted at the University
of Southern California (USC) NanoBiophysics Core Facility.
Atomic ForceMicroscopy (AFM)—Apo3G imaging buffer (25
mM HEPES, pH 7.3, 5 mM MgCl2, 0.1 mM dithiothreitol) and
sample were prepared as described previously (23). For experi-
ments done in the presence of DNA substrate, 400 nM (final
concentration) of ssDNA substrate was added to the Apo3G
sample (100 nM final concentration) before depositing as for the
protein alone. All AFM images were captured in air using a
Nanoscope IIIa (Digital Instruments, Santa Barbara, CA)
microscope in tapping mode. Experiments were conducted at
the USC NanoBiophysics Core Facility. Pointprobe Plus tap-
pingmode silicon probes (Agilent, Tempe, AZ) with resonance
frequencies of 170 kHz were used for imaging. Images were
collected at a speed of 2–3Hzwith an image size of 1 1mat
512  512-pixel resolution. Volume analysis was done as
described previously (32, 33). The SigmaPlot programwas used
to generate statistical plots.
Deamination Assays—Apo3G activity on ssDNA substrates
was measured in reactions containing 50 nM 32P-labeled DNA,
5 or 1000 nM Apo3G in buffer (50 mM HEPES, pH 7.3, 5 mM
MgCl2, 1 mM dithiothreitol) and incubated for 2.5–30 min at
37 °C. ssDNA substrates (0.5 M) with an internal fluorescein
label were incubated with Apo3G (15–1000 nM), and deamina-
tions were carried out as described above. Reactions were ter-
minated by an extraction with phenol/chloroform/isoamyl
alcohol (25:24:1), and deaminations were detected by the uracil
DNA glycosylase assay, as described previously (22). Gel band
intensities were visualized by phosphorimaging or with an FX
fluorescence scanner (Bio-Rad) and then measured with
ImageQuant software (GE Healthcare).
Pre-steady state reactions were mechanically sampled and
quenched using a KinTek quench-flow instrument as described
previously (23). Samples were then treated as described above.
Steady State Rotational Anisotropy Assays—Apo3G-RNA or
-DNA binding was monitored by changes in steady state fluo-
rescence depolarization (rotational anisotropy). Reaction mix-
tures (70 l), containing fluorescein-labeled RNA or DNA (50
nM) in buffer (50 mM HEPES, pH 7.3, 150 mM NaCl, 10 mM
MgCl2, 1 mM dithiothreitol) and varying concentrations of
0–2400 nM Apo3G, were incubated at 37 °C. Rotational aniso-
tropy was measured using a QuantaMaster QM-1 fluorometer
(Photon Technology International) with a single emission
channel. Samples were excited with vertically polarized light at
494 nm, and both vertical and horizontal emission was moni-
tored at 520 nm (4 nm band pass). The fractions of RNA or
DNA bound to protein were determined as described previ-
ously (34).
Pre-steady State Anisotropy Assays—Reactions were at 21 °C
in buffer containing 50 mM HEPES, pH 7.3, 5 mM MgCl2, and 1
mM dithiothreitol. Stopped-flow anisotropy measurements were
performedusing anAppliedPhotophysics*180 spectrofluorom-
eter equipped for anisotropy as described previously (23).
RESULTS
Apo3G exists as a combination of monomers, dimers, tet-
ramers, and higher oligomeric forms (23, 24) whose relative
distributions change significantly when bound to ssDNA (23).
Oligomerization appears to be essential for cellular functions
such as virion incorporation (7) and Alu retrotransposon
restriction (9, 27); however, the molecular interactions respon-
sible for forming the different oligomers are poorly defined.
Our principal objectives are: to determine the scanning, sub-
strate binding, and deamination properties of monomeric
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Apo3G; to compare the biochemical mechanisms of mono-
meric Apo3G with CD2 and with native Apo3G; and to deter-
mine the role of CD1 in the scanning mechanism. Therefore, it
is necessary to identify the amino acids responsible for oligo-
merization and introduce strategic mutations that interfere
with oligomer assembly and to verify the composition of
Apo3G native and mutant forms.
Generating Apo3G Oligomeriza-




based on the previously determined
crystal structures of the homolo-
gous Apo2 tetramer (28) and the
Apo3G CD2 domain (29), to design
Apo3G mutants that are predicted
to disrupt oligomerization. The
double-domain Apo3Gmonomer is
equivalent to the single-domain
Apo2 dimer. Furthermore, the
dimerization interface of Apo3G is
predicted to be equivalent to the
Apo2 tetramer interface. Apo2
tetramer oligomerization occurs
through a head-head (i.e. N-N)
dimer that forms a hydrophobic
dimer-dimer interface created by
residues found on loop 7 of each
dimer (28) (Fig. 1A). Through
sequence alignment of Apo2,
Apo3G CD1 domain (head), and
Apo3G CD2 domain (tail), the loop
7 cluster of residues was used to
identify homologous residues on
the equivalent loop 7 of the Apo3G
CD1 domain and Apo3G CD2
domain (supplemental Fig. S1). We
mutated these residues to alanine to
determine whether we could dis-
rupt oligomerization at the CD1
domain (Y124A/Y125A; F126A/
W127A; Fig. 1B) or CD2 domain
(R313A/ D316A/D317A/Q318A;
I314A/Y315A; Fig. 1C). Apo3G
dimerization could presumably
occur in a head-head (CD1-CD1,
Fig. 1D), tail-tail (CD2-CD2, Fig.
1E), or head-tail (CD1-CD2, not
shown) orientation. The hydropho-
bic residues located on loop 7 of
Apo2 are highly conserved in the
Apo3G CD1 domain (Fig. 1, A and
D, supplemental Fig. S1). This
homology is in contrast to the
Apo3G CD2 domain loop 72, which
contains mainly charged residues
that were previously shown to be
involved in DNA binding and specificity (29) (Fig. 1E,
supplemental Fig. S1). Based on these observations, we pre-
dicted that Apo3G dimerization occurs in a CD1-CD1 head-
head orientation (Fig. 1D).
MALS Analysis of the Oligomerization State of Native and
Mutant Apo3G Proteins—The oligomerization state of Apo3G in
native and mutant forms was determined using MALS (Fig. 2).
FIGURE 1. Predicted structural models of Apo3G dimerization based on the Apo2 structure. A, the solved
structure of the Apo2 tetramer containing hydrophobic residues (green sticks) on loop 7 that are at both the interface
and the outside surface. Each monomer is displayed as a different color, and the zinc atom is a red sphere. B, the
model of N-terminal (N-Term) Apo3G-CD1 (gray) shows the residues that were mutated to alanine. Tyr-124/Tyr-125
residues are shown as yellow sticks, and Phe-126/Trp-127 residues are shown as green sticks. C, the structure of
C-terminal (C-Term) Apo3G-CD2 (wheat) shows the residues that were mutated to alanine. Arg-313/Asp-316/Asp-
317/Gln-318 residues are shown as cyan sticks, and Ile-314/Tyr-315 mutant residues are shown as magenta sticks.
D, a zoomed in view of the proposed Apo3G dimer interface in a head-head (CD1-CD1) configuration. Hydrophobic
residues Tyr-124/Tyr-125 (yellow) and Phe-126/Trp-127 (green) on loop 7 (L7) were mutated to alanine and may be
involved in forming a hydrophobic core at the dimer interface, similar to hydrophobic residues found in the equiv-
alent loop in the Apo2 tetramer interface. E, a zoomed in view of the proposed Apo3G dimer interface in a tail-tail
(CD2-CD2) configuration. Charged residues Arg-313/Asp-316/Asp-317/Gln-318 (cyan) and Ile-314/Tyr-315 (purple)
were mutated to alanine and may be involved in forming a dimer interface using loop 7 (L72), which has previously
been shown to interact with the DNA substrate (29, 36, 39).
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Purified protein is injected into a high pressure liquid chromatog-
raphy size-exclusion column followed in series by detectors that
measure UV absorbance, MALS, and refractive index (35) (see
“Experimental Procedures”). The light-scattering chromatogram
(Fig. 2A, Raleigh ratio, right y axis) in combinationwith themolec-
ular mass line plot (Fig. 2A, left y axis) shows that native Apo3G
(predicted molecular mass 46.4 kDa) is present primarily as a
dimer (80%, molecular mass 113 kDa) along with a small but
significant population of monomers (18%) and 2% higher
orderoligomerswithanaveragemolecularmassof650kDa (Fig.
2A) (35). The molecular mass line plots, which plot the mass
throughout the peak, each have a steep slope, demonstrating that
native Apo3G is polydisperse in aqueous solution in the presence
of salt (200 mM Na2SO4). There appear to be unresolved mono-
mers, trimers, and tetramers contained in the dimer peak (Fig. 2A,
line plot, left y axis). This result is in contrast to the constantmass
plotted throughout the peak of amonodisperse protein, i.e.bovine
serum albumin (supplemental Fig. S2). Similar results for native
Apo3G were found over a 4-fold concentration range, suggesting
that dilution of the protein during gel filtration is unlikely to be
causing dissociation of multisubunit structures (data not shown).
We performed aMALS analysis on fourApo3Gmutants pre-
dicted to interfere with oligomerization, based on crystal con-
tacts in the Apo2 tetramer structure (28) (Fig. 1). Two mutants
are located in theN-terminal CD1 domain (F126A/W127A and
Y124A/Y125A) and two are in the C-terminal CD2 domain
(R313A/D316A/D317A/Q318A and I314A/Y315A).
Mutant F126A/W127A causes a severe disruption in olig-
omer formation resulting in about 92% monomers and 8%
dimers, with no larger oligomer forms detected (Fig. 2B,N-mu-
tant F/W). The small population of dimers may result from
residual CD1-CD1 interactions, perhaps from relatively weak
tail-tail CD2-CD2 or head-tail CD1-CD2 interactions. It
appears that the oligomer forms of Apo3G are stabilized in the
presence of salt via hydrophobic interactions involving CD1,
with just the two adjacent residues, Phe-126 and Trp-127, play-
ing a dominant role. In contrast, the CD1 residues Tyr-124 and
Tyr-125 have a far less significant role in oligomer formation.
Themutant Y124A/Y125A is composed of roughly 47%mono-
mers, 42% dimers, 10% tetramers, and 1% much larger molec-
ular mass species (650 kDa) (Fig. 2C, N-mutant Y/Y). The
absorbance chromatogram is used in place of the Rayleigh
light-scattering ratio (35) to depict the forms for the Apo3G
N-mutant Y124A/Y125A (Fig. 2C, chromatogram, right y axis)
because of a stronger signal, but the two profiles are similar
(data not shown). The molecular mass values associated with
each absorbance peak are obtained from an analysis of MALS
(35) (Fig. 2C, line plot, left y axis).
The quadruple mutant, R313A/D316A/D317A/Q318A,
in the CD2 domain of Apo3G (Fig. 2D,C-mutant), corresponds
to the region at the Apo2 tetrameric interface and predicted
CD1 oligomerization region (residues 124–127), based on
sequence alignment (supplemental Fig. S1). However, the CD2
domain does not contain the hydrophobic residues conserved
FIGURE 2. Determination of the molecular mass of Apo3G native and
mutants by MALS. Apo3G native and mutants were resolved by size-exclu-
sion chromatography in running buffer with 200 mM NaSO4 and 50 mM
HEPES, pH 6.7. The molecular mass is plotted throughout the eluted peaks
(line plot, left y axis). The Rayleigh light scattering (35) or UV absorbance chro-
matograms showing the protein distributions are plotted on the right y axis.
A, the median molecular masses and distributions for Apo3G native are 18%
monomers (51 kDa), 80% dimers (113 kDa), and 2% large molecular mass
species (650 kDa). B, the median molecular masses and distributions for
F126A/W127A mutant (N-mutant F/W) are 92% monomers (43 kDa) and 8%
dimers (63 kDa). C, the median molecular masses and distributions for Y124A/
Y125A mutant (N-mutant Y/Y) are 47% monomers (42 kDa), 42% dimers (67
kDa), 9% tetramers (117 kDa), and 1% large molecular mass species (650 kDa).
D, the median molecular masses and distributions for R313A/D316A/D317A/
Q318A (C-mutant) are 23% monomers (46 kDa), 65% dimers (99 kDa), and
12% tetramers (216 kDa). The chromatograms for A, B, and D correspond to
the relative intensity of light scattering (right y axis). The chromatogram for C
corresponds to the relative intensity of absorption at 280 nm (right y axis).
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in CD1 andApo2; these residues have previously been shown to
be involved in substrate specificity (29, 36, 37). The Apo3G
C-mutant (23% monomer, 65% dimer, Fig. 2D) and native
Apo3G (18% monomer, 80% dimer, (Fig. 2A) are roughly com-
parable. However, the C-mutant contains about 12% tetramers
with no larger oligomeric forms (Fig. 2D), whereas the native
protein contains some tetramers (molecular mass 190 kDa),
but they cannot be resolved in the dimer peak (Fig. 2A). Native
Apo3G contains a small amount (2%) of 14 subunit olig-
omers, molecular mass  650 kDa (compare Fig. 2D with Fig.
2A). Apparently, these C-terminal residues are needed to
form large oligomers, but because there is no substantial
effect on dimer formation, perhaps these amino acids are
restricted to tail-tail interactions (Fig. 1E). If this supposition
is valid, then because the effects of mutating these C-termi-
nal residues are relatively minor, it suggests that tail-tail
interactions do not establish a major dimer interface,
whereas the N-terminal CD1 residues do establish a major
dimer interface via head-head interactions. Similar results
were found with the C-terminal mutant I314A/Y315A
(supplemental Fig. S3).
AFMComparison of Apo3GNative and N-mutant F/WOlig-
omeric Forms—The MALS analysis provides a characteriza-
tion of native and mutant forms of Apo3G in solution in the
absence of ssDNA (Fig. 2). The olig-
omeric forms of native Apo3G
change significantly in the presence
of ssDNA (23). We used AFM to
image the native and monomer
N-mutant F/W forms of Apo3G
with and without DNA (Fig. 3,
supplemental Fig. S4). The volume
of the deposited protein determined
from theAFM images can be used to
examine the distribution of oligo-
meric states because the AFM vol-
ume of proteins exhibits a linear
relationship with molecular weight
(32, 33), with volume 14.7 1.2
(molecular weight). In the absence
of ssDNA and presence of Mg2,
which is used to facilitate AFM
imaging, both native Apo3G (23)
(Fig. 3A) and the N-mutant F/W
(Fig. 3C) have large monomer pop-
ulations. In contrast, in the presence
of ssDNA, native Apo3G contains a
broad distribution of monomers,
dimers, tetramers, and higher order
oligomers (Fig. 3B), whereas the
monomericN-mutant F/Wremains
principally monomeric whether or
not ssDNA is present (Fig. 3D).
Apo3G-catalyzed 335 Deami-
nation Polarity and Processivity Are
Determined by the Non-catalytic
N-terminal CD1 Domain—Native
Apo3G, composed of a mix of
monomers and oligomers, has been shown to catalyze pro-
cessive C-deamination with a strong bias favoring deamina-
tion in target motifs located toward the 5-region of linear
ssDNA in the presence of salt (23) (Fig. 4A, Native). The
native enzyme deaminates the 5-CCC target motif 5-fold
more rapidly than the 3-CCC motif (Fig. 4A, Deamination
ratio, 5-C/3-C  5). The N-mutant F/W, which is predom-
inantly a monomer, shows an 11-fold bias favoring the
5-deamination motif (Fig. 4A, N-mutant F/W). The reac-
tions are performed under “single-hit” conditions ( 15%
substrate usage), which, by Poisson statistics (38), ensures
that any given ssDNA substrate is acted on by at most one
form of Apo3G (monomer or oligomer). The deamination
band at 5-C and 3-C, observed for the native and N-mutant
F/W enzymes, results from processive double deaminations
carried out principally by a single enzyme (22, 23). Thus, the
Apo3G monomeric mutant deaminates C3U, processively
on ssDNA with a strong 335 directional bias. Apo3G does
not need to oligomerize to carry out either processive or
directional deamination.
The C-terminal CD2 catalytic domain alone, which does not
oligomerize, can catalyze ssDNA-dependent C3U deamina-
tion in the absence of the non-catalytic CD1 (29, 36, 39). The
5-C and 3-C deamination bands have similar integrated
FIGURE 3. Oligomerization state of Apo3G native and N-mutant F/W in the absence and presence of
ssDNA. AFM imaging was done in the presence of 5 mM MgCl2. The oligomeric state of native Apo3G alone (A)
and in the presence of ssDNA (B) demonstrated that the Apo3G native composition shifts from a distribution of
mostly monomers (A) to a broad distribution of oligomers in the presence of ssDNA (B). The oligomer interface
N-mutant F/W imaged by AFM in the absence (C) and presence (D) of ssDNA did not demonstrate a significant
shift in composition upon the addition of ssDNA. Volume distributions of Apo3G are plotted against percent-
age of total proteins. The predicted peaks for a monomer (42 nm3), dimer (97 nm3), and tetramer (208 nm3) are
denoted with a bracket. Total volume distribution is to 1000 nm3 (see supplemental Fig. S4). Partial volume
distribution is shown here to give a focused view of the major monomer, dimer, and tetramer populations. For
Apo3G native and Apo3G N-mutant F/W, the population that distributes from 0 to 240 nm3 is 60 and 90%
of the total proteins, respectively. The total proteins counted were: A, 285; B, 722; C, 242; and D, 588. Repre-
sentative AFM images of Apo3G native and the N-mutant F/W are shown for each condition. Images are 300 
300 nm with a height scale of 5.5 nm.
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intensities (Fig. 4A, CD2,Deamination ratio, 5-C/3-C  1.4),
and there is no detectable 30-nt double deamination band.
Therefore, unlike either the Apo3G native or the N-mutant
F/W, CD2 acts non-processively with essentially no directional
bias.
The 335 deamination bias can be examined directly by
measuring the specific activity of Apo3G acting on a single
5-CCC motif located at different distances (d) from the
3-ssDNA end. Deamination is strongly favored at the 5-end
(Fig. 4B), where the specific activity for the monomeric N-mu-
tant F/W (20 pmolg1min1) is2-fold higher than native
enzyme (12 pmol g1 min1). There is a 20-foldmonotonic
increase in specific activity for both enzyme forms as the target
C residue in the 5-CCC motif (underlined C is deaminated) is
moved in a 3 to 5 direction, from nucleotide position 33 to
position 66 (Fig. 4B). In contrast, CD2 has 1000-fold lower
specific activity (0.010 pmol g1 min1), which does not
depend on the location of the CCC motif (Fig. 4B, inset).
The 30-nt region at the 3-end constitutes a deamination
“dead zone” (23). Within the dead zone, the Apo3G native and
N-mutant F/W deamination activities show a steep, i.e. discon-
tinuous, loss of deamination activity, which remains at a con-
stant depressed level irrespective of motif location (Fig. 4B).
NativeApo3Ghas a specific activity0.07 pmolg1min1 in
the 30-nt dead zone, which shows a stepwise jump of 50-fold
to 3.8 pmol g1 min1 at CCC (nt 33), located 3 nt out of the
dead zone. The N-mutant F/W has a specific activity of 0.5
pmol g1 min1 in the dead zone, which jumps by 4-fold to
2.0 pmol g1 min1 at nt 33. The deamination activity of
CD2 stays constant outside and inside the dead zone (Fig. 4B,
inset), in contrast to the monomeric N-mutant F/W, which
favors 335 deamination outside the dead zone (Fig. 4B).
These data suggest that when CD1 is present with CD2, the
non-catalytic CD1 domain imposes an asymmetric 335
catalytic constraint.
Comparison of Apo3G Native and Monomeric N-mutant
F/W ssDNA Substrate Binding and Catalysis—A quench-flow
analysis was used to determine the single-turnover C-deamina-
tion rates for the native and monomeric N-mutant F/W at two
locations, one close to the 5-ssDNAend (Fig. 5A) and the other
nearer to the 3-end but outside the 30-nt dead zone (Fig. 5B). A
10-fold molar excess of Apo3G (500 nM) over ssDNA (50 nM) is
sufficient to saturate the substrate and allows ameasurement of
the maximum rate to convert C3U, at the two CCC motif
positions.
Native Apo3G converts CCC3CCU 2.7-fold faster when
it is 57 nt (Fig. 5A, 0.52 s1) versus 36 nt from the 3-end (Fig.
5B, 0.19 s1). The more rapid turnover at the 5-motif is con-
sistent with the favored 335 deamination polarity (Fig. 4A,
Native, deamination ratio 5-C/3-C  5). The data for the
5-motif fit well to a single exponential, whereas the data for the
3-motif are biphasic with 56% of the turnovers occurring at a
rate of 0.19 s1 and 44% occurring at a 200-fold slower rate
(0.001 s1).
The monomeric N-mutant F/W deaminates the 5-CCC
motif at a maximum rate of 0.11 s1 (Fig. 5A) when compared
with 0.06 s1 for the 3-motif (Fig. 5B). Similar to the native
enzyme, the kinetic data for the N-mutant F/W fit best to a
single exponential for the 5-motif and to a double exponential
for the 3-motif, 39% of the turnovers occurring at 0.06 s1 and
61% occurring at a 15-fold slower rate (0.004 s1). In compari-
son with native Apo3G, the N-mutant F/W has an 5-fold
slower maximum C3U turnover rate at the 5-motif (0.11 s1
versus 0.52 s1) and an3-fold slower rate at the 3-motif (0.06
s1 versus 0.19 s1).
Stopped-flow fluorescence measurements were used to
determine the kinetics of binding by Apo3G native and N-mu-
tant F/W enzymes (Fig. 5, C and D). The on-rates, measured
using 20-fold excess enzyme over DNA, are rapid; about half
the binding occurs within the instrument dead time (1.1 ms)
(Fig. 5, C and D). The kinetics are biphasic, characterized by a
faster rate of 297 s1 and slower rate of 8 s1, for native Apo3G
(Fig. 5C) when compared with 201 and 12 s1 for theN-mutant
F/W (Fig. 5D). The heterogeneity in binding for the native
enzyme is probably caused by the heterogeneous forms of the
enzyme in solution (Fig. 2A), consistent with previous binding
studies (23). In the case of theN-mutant F/W,which is predom-
inantly a monomer (Fig. 2B), the small fraction of oligomer
forms could assemble at high protein concentrations. Consis-
tentwith this supposition, a 5-fold reduction inApo3G concen-
tration (4-fold excess enzyme over DNA) causes the N-mutant
FIGURE 4. Processivity, polarity, and specific activity of the Apo3G native,
N-mutant F/W, and CD2 domain. A, native and mutant Apo3G were incu-
bated with an 85-nt internally fluorescein-labeled ssDNA substrate with two
CCC motifs 28 nt apart. Single deaminations of the 5-C and 3-C are detected
as the appearance of labeled 67- and 48-nt fragments, respectively; double
deamination of both C residues on the same molecule results in 30-nt labeled
fragment (5-C and 3-C). Deamination ratios of the 5-C and 3-C deamina-
tions are shown below each gel. The enzyme to DNA ratio varied from 1:20 to
1:1, depending on the specific activity, to obtain a substrate usage of up to
15% in a timed reaction. B, specific activity and polarity of Apo3G native (F),
N-mutant F/W (Œ), and CD2 domain (f) plotted as a function of the distance
(d) of the CCC motif from the 3-end of a 69-nt ssDNA substrate (50 nM). Inset,
an expanded view of the specific activity of the CD2 domain. Error bars indi-
cate S.E.
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F/W binding to become monophasic (supplemental Fig. S5B;
rate  208 s1), with a single on-rate that is approximately the
same as measured at the high enzyme to DNA ratio (Fig. 5D;
faster rate  201 s1). Therefore, there may be a reduction in
oligomerization occurring at the lower enzyme/DNAratio (4:1)
for the N-mutant F/W. Biphasic binding is retained for the
native enzyme (supplemental Fig. S5A; faster rate  79 s1,
slower rate  8 s1).
The off-rates of the native and
N-mutant F/W enzymes are bipha-
sic (Fig. 5, E and F). Roughly 40% of
the native Apo3G remains bound
for 20 s, and 60% remains bound for
200 s (Fig. 5E). About 43% of the
Apo3G N-mutant F/W remains
bound for 6 s, and 57% stays bound
for 60 s (Fig. 5F). The N-mutant
Apo3G dissociates from ssDNA
3–5-fold faster than the native
form(s) of the enzyme. Taken
together with the rapid kinetic
C3U turnover data (Fig. 5, A and
B), the enzymes remain bound in
their various forms for sufficient
time to catalyze from as little as 8 to
as many as 80 deaminations for the
native enzyme and from 0.5 to 5
deaminations for the N-mutant
F/W.
Interaction of Apo3G N-mutant
F/W with Alu RNA—The Apo3G
residue Trp-127 appears to be
required for two cellular functions
that involve RNA binding, virion
incorporation (9, 27, 40, 41), and
Alu retrotransposon restriction (9).
Furthermore, oligomerization has
been considered necessary for
Apo3G to bind RNA (27). We have
determined the binding affinity of
Apo3G native and N-mutant F/W
for twoAlu RNAs; one is a 91-nt Alu
sequence derived from 7SL RNA
(9), and the other is a small cytoplas-
mic Alu RNA, which is a product of
RNA processing (42, 43).
Native Apo3G binds 7SL Alu
RNA with 2.5-fold higher affinity
than theN-mutant F/Wwith appar-
ent dissociation constants (Kd) of
446 and 1200 nM, respectively (Fig.
6A). The Apo3G native and N-mu-
tant F/W bind a 108-nt small cyto-
plasmic Alu (scAlu) (native Kd of
220 nM; N-mutant F/W Kd of 357
nM, Fig. 6B) or 40-nt random RNA
sequence (native Kd of 298 nM;
N-mutant F/W Kd of 211 nM, data
not shown) with approximately the same affinity. AFM was
used to determine whether Apo3G native and N-mutant F/W
form oligomers on 7SL-derived Alu RNA. In the presence of
91-nt Alu RNA, the Apo3G native volume distribution shifts
from a relatively narrow distribution of mostly monomers (Fig.
3A) to a broad distribution of oligomeric forms (Fig. 6C,
supplemental Fig. S6A), similar to when DNA is present (Fig.
3B). The N-mutant F/W is present mostly as a monomer alone
FIGURE 5. Pre-steady state analysis of deamination and binding of Apo3G native and N-mutant F/W on
ssDNA. A and B, pre-steady state analysis of deamination rates of Apo3G native and N-mutant F/W on ssDNA.
Single turnover reaction rates for Apo3G native (F) and N-mutant F/W (Œ) were determined on ssDNA sub-
strates with CCC motifs 57 (A) or 36 nt (B) from the 3-end of a 69-nt substrate under enzyme saturating
conditions (500 nM Apo3G, 50 nM DNA). Error bars indicate S.E. C and D, stopped-flow fluorescence pre-steady
state interactions of Apo3G native and N-mutant F/W. The on-rate of Apo3G native (C) and N-mutant F/W (D)
was determined when 1 M enzyme was added to a 69-nt fluorescein-labeled (denoted with an F) ssDNA
substrate (100 nM) by monitoring changes in rotational anisotropy of free ssDNA (gray line) following the
addition of Apo3G as a function of time. E and F, the off-rate of 0.2 M of Apo3G native (E) and N-mutant F/W (F)
dissociating from fluorescein-labeled DNA (50 nM) was determined by preincubating Apo3G with ssDNA (gray
line) and monitoring changes in rotational anisotropy following the addition of 100-fold excess unlabeled
69-nt ssDNA as trap (black line). The anisotropy of free fluorescein-labeled ssDNA mixed with unlabeled ssDNA
trap is denoted with a horizontal line. Data were fit to either a double or a single exponential to obtain rates.
Kinetic rates are discussed under “Results” and listed in supplemental Table S3.
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(Fig. 3C), when bound to RNA (Fig. 6D, supplemental Fig. S6B),
and when bound to DNA (Fig. 3D). These data demonstrate
that Apo3G monomers are able to bind RNA.
DISCUSSION
There are questions concerning the composition of Apo3G
prior to its encapsulation in an HIV virion as a “Trojan horse”
and after its entry in T cells. It is generally agreed that Apo3G is
encapsulated as amultimer, perhaps by interactingwith theAlu
portion of 7SL RNA or HIV RNA, but presumably not as a
monomer (7, 14). However, in contrast to a currently favored
model for Apo3G encapsulation (27), which implies that mul-
timerization is necessary for RNA binding, our data show that
Apo3Gmonomers are also able to bind RNA (Fig. 6). Although
Apo3G may enter the virion as an RNA-induced multimer (7,
25) that is disrupted by RNase H to release Apo3G monomers
and dimers (25), it is not certain what form Apo3G takes when
catalyzing deaminations of HIV proviral cDNA.
Exploring the Composition of Apo3G—The uncertainty in the
composition of native Apo3G stems from its ability to assume
several different forms. Low angle x-ray-scattering and cross-
linking experiments showApo3Gdimers (27, 44) that appear to
be arranged in either a head-to-head
configuration with the two N-ter-
minal CD1 domains bound (27) or a
tail-to-tail configuration with the
two C-terminal CD2 domains
bound (45). Using MALS, we find
that Apo3G in solution has a poly-
disperse light-scattering peak con-
taining mostly dimers (Fig. 2A,
80%), along with monomers pres-
ent at the lowmolecularmass side of
the main peak and unresolved trim-
ers and tetramers at the highmolec-
ular mass side of the peak (Fig. 2A),
in agreement with recent analytical
ultracentrifugation data (24). An
analysis of Apo3G composition
using AFM further reveals that
although in the absence of ssDNA,
Apo3G exists mainly as monomers
anddimers, with aminority of larger
species (Fig. 3A), there is significant
increase in the percentage of tri-
mers, tetramers, and large oligomers
that appear in the population in the
presence of ssDNA (Fig. 3B). There-
fore, it seems plausible that native
Apo3Gmay act on ssDNA in a vari-
ety of different forms (23).
We have used the crystal struc-
ture of Apo2 (28) (Fig. 1A) to iden-
tify homologous amino acids to
mutate in the N-terminal CD1
domain of Apo3G that corresponds
to the Apo2 hydrophobic interface
(Fig. 1B, supplemental Fig. S1). Dis-
ruption of this predicted interface should interfere with N-ter-
minal head-to-head dimerization, thereby generating Apo3G
monomers. One such mutant, F126A/W127A (N-mutant
F/W), resulted in predominantly monomers (92%) (Fig. 2B)
that remain as monomers in the presence of ssDNA (compare
Fig. 3C with Fig. 3D). In contrast, the native Apo3G exhibits a
major change in composition in the presence of ssDNA (com-
pare Fig. 3A with Fig. 3B). Because native Apo3G can form
oligomers larger than dimers, either in solution (Fig. 2A) or
when bound to ssDNA (Fig. 3B), an additional oligomer inter-
face apart from CD1-CD1 is likely to exist. The C-terminal
mutants R313A/D316A/D317A/Q318A and I314A/Y315A
have fewer larger molecular mass species when compared
with native Apo3G (Fig. 2, A and D, supplemental Fig. S3)
suggesting that large complexes may form through the CD2-
CD2 interface.
Comparing Polarity and Processivity of Native Apo3G with
Monomeric Apo3G and CD2—A side-by-side comparison of
native, N-mutant F/W, and catalytic CD2 Apo3G shows that
themonomermutant retains the biochemical characteristics of
the native enzyme, such as 335 deamination polarity (22, 23)
and processivity (22, 23), whereas CD2 (lacking CD1) does not
FIGURE 6. Apo3G native and N-mutant F/W interactions with Alu RNAs. A and B, the apparent dissociation
constant (Kd) of Apo3G native and mutants from Alu RNAs was determined by monitoring changes in rotational
anisotropy of free fluorescein-labeled RNA (50 nM) following the addition of enzyme as a function of concen-
tration. A, Apo3G native (F) binds to a 91-nt Alu RNA sequence derived from 7SL RNA with an apparent Kd of
446 nM, which is a 2.5-fold higher affinity interaction than for the N-mutant F/W (Œ, Kd of 1200 nM). B, the Apo3G
native (F) and N-mutant F/W (Œ) bind a 108-nt small cytoplasmic Alu (scAlu) RNA with approximately the same
affinity, having an apparent Kd of 220 and 357 nM, respectively. C and D, AFM was used to determine the
oligomeric state of Apo3G native (C) and N-mutant F/W (D) in the presence of a 91-nt Alu RNA and 5 mM MgCl2.
The apparent dissociation constants for native and mutant Apo3G in the AFM buffer were 374 and 742 nM,
respectively. Volume distributions of Apo3G are plotted against a percentage of total proteins. The predicted
peaks for a monomer (42 nm3), dimer (97 nm3), and tetramer (208 nm3) are denoted with a bracket. Total
volume distribution is to 1000 nm3 (see supplemental Fig. S6). Partial volume distribution is shown here to give
a focused view of the monomer, dimer, and tetramer populations. For Apo3G native and N-mutant F/W, the
population that distributes from 0 to 240 nm3 is 50 and 80%, respectively. Total proteins counted were:
C, 361; and D, 211. Representative AFM images of Apo3G native and N-mutant F/W are shown for each condi-
tion. Images are 300  300 nm with a height scale of 5.5 nm.
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(Fig. 4A). The monomer mutant
deaminates both 5-CCC and
3-CCC target motifs processively,
with an 11-fold directional bias
favoring deamination of the 5-mo-
tif over the 3-motif (Fig. 4A,Native
and N-mutant F/W lanes). There is
a 30-nt dead zone region at the
ssDNA 3-end characterized by a
stepwise drop in specific activity,
50-fold for native Apo3G and 4-fold
for the N-mutant F/W monomer
(Fig. 4B).
Unlike native Apo3G and the
monomeric N-mutant F/W, CD2
specific activity is roughly constant
over the entire ssDNA molecule
(Fig. 4B); it is not processive (Fig.
4A, CD2 lane), shows no deamina-
tion polarity (Fig. 4, A and B), and
has no dead zone (Fig. 4B, inset).
The catalytically activeCD2domain
has a net negative charge (4.5),
whereas the inactive CD1 domain
has a large net positive charge
(11). In the absence of CD1, the
apparent Kd for ssDNA of the CD2
domain increases from 0.15 to 12
M (data not shown), which proba-
bly accounts for the loss of proces-
sive deaminations. Mutating two
residues, Phe-126 and Trp-127 to
Ala, causes a 5-fold decrease in the
catalytic rate (Fig. 5, A and B) and a
3–5-fold increase in the off-rate
(Fig. 5, E and F). Thus, the non-cat-
alytic CD1 plays an indispensable
role in stabilizing ssDNA binding,
enhancing catalysis, and establish-
ing 335 deamination polarity and
processivity. Our data indicate that
the functions of the CD1 and CD2
domains are not nearly as segre-
gated as suggested previously, i.e.
with CD1 responsible for encapsi-
dation of Apo3G into virions and
CD2 for catalysis (21, 46, 47).
Although it is true that the chemis-
try of the deamination reaction
occurs solely in the CD2 domain,
CD1 clearly has a major influence
on catalysis.
Structure-basedModel for Apo3G
Polarity and Processivity—All pre-
vious studies with purified native
Apo3Gwere performed using a het-
erogeneous mix of monomers,
dimers, and higher order oligomers
FIGURE 7. Models of Apo3G with ssDNA. A, the Apo3G crystal structure was modeled with a short piece of
ssDNA containing the CCC hot spot. The Apo3G-CD2 crystal structure (shown in wheat) was superimposed with
the mouse cytidine deaminase co-crystal structure with cytidine in the active site (PDB 2fr6) to place the
cytosine base in this position (shown in red). Residues on loop 7 (L72) have previously been shown to be
important for Apo3G substrate specificity (29, 36, 39) (shown in green), specifically, Asp-316 and Asp-317 (29).
Other residues on L72 may contact the bases neighboring the target cytosine through electrostatic, hydropho-
bic, or base-stacking interactions. It is predicted that for Apo3G to efficiently deaminate the target cytosine at
position 0, the DNA (shown in blue, with the 2 and 1 cytosines shown as sticks) should be positioned in a
533 orientation across L72 to allow the hot spot cytosines to interact with the residues on L72. Exactly how
these residues interact with the cytosines remains unknown. B, an Apo3G monomer can bind ssDNA in either
orientation, but only the active orientation is efficient for cytosine deamination. Top, Apo3G is shown in the
active orientation that allows for the Apo3G-CD2 (crystal structure shown in wheat) to bind DNA so that the hot
spot CCC motif (red) binds L72 in a 533 orientation. Apo3G-CD1 (gray circle) is more positively charged and
binds DNA (black line) with a higher affinity than Apo3G-CD2. Bottom, Apo3G is shown in the inactive orienta-
tion where the Apo3G-CD2 residues on L72 are predicted not to contact the hot spot motif. Because this
interaction is important for recognizing the target cytosine, in this orientation, Apo3G-CD2 would not be able
to efficiently deaminate the CCC motif (blue). C, Apo3G-CD2 is capable of deaminating in the dead zone.
Apo3G-CD2 (wheat) is not restricted and can deaminate the target cytosine (red) in the dead zone (slashed black
lines). D, the monomer Apo3G, although positioned in the active orientation, does not deaminate cytosine in
the dead zone. Apo3G-CD1 (gray circle) binds DNA tightly and may restrict deamination in the dead zone
(slashed black lines) by blocking Apo3G-CD2 (wheat) access to the target cytosine (blue). However, CCC motifs
upstream of the dead zone can be deaminated (red). E, a predicted model of the Apo3G dimer in a head-head
orientation capable of deaminating the ssDNA 5-proximal CCC motif. The Apo3G-CD2 near the 5-end of the
DNA is positioned in the active orientation to deaminate the 5-CCC motif (red). The Apo3G-CD2 positioned
near the 3-end of the DNA is in the inactive orientation and inefficiently deaminates the 3-CCC motif (blue) in
the dead zone (slashed black lines).
Role of Apo3G CD1 Domain in Oligomerization and Deamination
MAY 21, 2010 • VOLUME 285 • NUMBER 21 JOURNAL OF BIOLOGICAL CHEMISTRY 16203
in solution, which exhibit severe changes in composition ratio
in the presence of ssDNA (Fig. 3, A and B) and salt (23). It is
seemingly impossible to determine a mechanism of scanning
and deamination using data from a complex and variablemix of
native forms. In contrast, our present study, showing that the
N-mutant F/W monomer retains all of the salient catalytic
properties of the mix of species of the native enzyme (Fig. 4),
enables us to propose a structure-based model for Apo3G
ssDNA scanning and deamination (Fig. 7).
The presence of 335 catalytic directionality appears to be
imposed by a constraint within the active site of the enzyme
such that a 5-CCCmotif, situated anywhere along ssDNA, is in
a favorable orientation for deamination when bound with the
first (2) and second (1) C in the 5-CCC motif extending
away from the zinc atom within the active center toward
loop 72 (Fig. 7A). Residues on loop 72 of the CD2 domain are
required for deamination (29, 36, 39) and important for deami-
nation specificity (29). The pyrimidine rings of the 2 and 1
C residues of the CCCmotif are essential for motif recognition
and deamination of the third (0) C residue, thus corroborating
a favored binding orientation within the active site, one that is
most efficient for deamination (48). The biochemical data (Fig.
4, A and B) and structural modeling (Fig. 7A) suggest that
Apo3G catalyzes deaminationmost efficiently when approach-
ing the deamination target with the CD2 domain oriented
toward the 5-ssDNA end (Fig. 7B, Active Orientation). The
reverse orientation is unlikely to allow contact between resi-
dues of loop 72 and the2 and1C residues in the CCCmotif,
precluding the proper geometry for the C at position 0 in the
motif to orient with the zinc molecule as required for deamina-
tion (Fig. 7B, Inactive Orientation). The model clearly suggests
why it is the C at position 0 in any given 5-CCC motif that is
deaminated in strong preference to the other two C residues.
After binding randomly to DNA (22), because there is no
apparent energy source present, Apo3G translocates randomly
in small steps by sliding (22, 23) and in larger steps by jumping/
hopping (22, 23) or intersegmental transfer (49). The deamina-
tions occur processively, i.e. one Apo3G molecule (monomer,
dimer, tetramer) catalyzes multiple deaminations on the same
ssDNA prior to attacking a different substrate (22, 23).
Although randommovements in the 5- and 3-directionsmust
on average be the same, the catalytic orientational specificity
always favors deamination toward the 5-side (Fig. 7B, Active
Orientation). Thus, Apo3G is predisposed to exhibit a deami-
nation polarity. The presence of a dead zone located at the
3-ssDNA end (Fig. 4B) also suggests the presence of a favored
catalytic orientation. BecauseCD2-catalyzed deamination does
not depend on motif location, i.e. it has no dead zone (Figs. 4B
and 7C), we speculate that CD1, because of its large overall
positive charge and high affinity for DNA, creates a dead zone
whenever it binds randomly in the last 30 nt of the 3-ssDNA
end, thereby shielding targets from being deaminated by CD2
(Fig. 7D). CD2 acts mainly as a catalyst, which is active when
oriented facing the 5-end of the ssDNA butmuch less so when
facing the 3-end (Fig. 7B). The same generalmodel can be used
to explain directional deamination for an Apo3G monomer
(Fig. 7D), for a dimer (Fig. 7E), and for larger oligomers.
One prediction of the model is that an enhanced mobility of
the enzyme on the ssDNA would enable increased sampling of
all CCC motifs, located either 5 or 3 to the original binding
site. Once a favored 5-motif is deaminated, a more mobile
enzyme can slide and jump back to sample a 3-motif more
efficiently than a lessmobile enzyme, resulting in a reduction in
the 5-C/3-C deamination ratio. Examination of data on
Apo3G binding and deamination polarity in the presence and
absence of salt (Mg2) supports this prediction (supple-
mental Fig. S7). Both the native and the monomer mutant of
Apo3G bind less tightly to the ssDNA in the absence of salt (Kd
of 418 and 320 nM, respectively) than in its presence (Kd of 153
and 107 nM, respectively), and both show a substantial reduc-
tion in the deamination polarity in the absence of salt (compare
supplemental Fig. S7Awith Fig. 4A). Further evidence suggest-
ing that weaker interactions lead to greater mobility comes
from examination of the fluorescence of ssDNA containing
pyrrolo-dC (see supplemental “Experimental Procedures”),
which is a “marker” of DNA conformational alterations (50).
Changes in pyrrolo-dC fluorescence occur only after Apo3G
binds to the ssDNA (23) and therefore reflect DNA conforma-
tional alterations during enzyme translocation (supplemental
Fig. S7, D and E). Notably, both native and monomeric Apo3G
show smaller intensity changes when they scan the ssDNA
backbone in the absence versus the presence of salt (sup-
plemental Fig. S7, B and C), consistent with their decreased
binding affinities. In addition, in the presence of salt, theApo3G
monomer causes greater structural changes when compared
with the native enzyme (supplemental Fig. S7, B and C), and the
monomer has a 2-fold higher 335 deamination bias (Fig. 4A,
Deamination ratio, 5-C/3-C 11 and 5, for themonomer and
native enzyme forms, respectively). These data suggest that the
positively charged CD1 domain, by binding the DNA with
either low or high affinity (low or high salt conditions, respec-
tively), can either enhance or restrict the movement of Apo3G
on the DNA.
The structure-based model (Fig. 7) explains why deami-
nation is favored in a 5-direction. The monomer data are
essential to explain the properties of the native forms ofApo3G.
Key to the model is the observation that the Apo3G monomer
mutant retains the biochemical features of processivity and
deamination polarity exhibited by the nativemix ofmonomers,
dimers, and larger oligomer forms. The features of processivity
and polarity are determined by the CD1 domain of the mono-
mer, thus revealing the overriding importance of the non-cata-
lytic CD1 in the spatial properties of deamination and in impos-
ing an asymmetric catalytic constraint on full-length Apo3G.
These properties are responsible for generating 335 deami-
nation gradients on ssDNA in vitro, which correspond tomuta-
tional gradients in HIV RNA observed in vivo (16, 22, 23, 51).
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